These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7860030)

  • 1. Hair analysis: a worthless tool for therapeutic compliance monitoring.
    Tracqui A; Kintz P; Mangin P
    Forensic Sci Int; 1995 Jan; 70(1-3):183-9. PubMed ID: 7860030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair it is: the long and short of monitoring antiretroviral treatment.
    Gandhi M; Greenblatt RM
    Ann Intern Med; 2002 Oct; 137(8):696-7. PubMed ID: 12379072
    [No Abstract]   [Full Text] [Related]  

  • 3. [Establishment of a method to analyze drugs in the hair and its application for determining patient compliance].
    Uematsu T
    Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):475-83. PubMed ID: 1483601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients. The relationship between levels of the anti-HIV drug indinavir in patients' hair and response to treatment.
    Ann Intern Med; 2002 Oct; 137(8):I48. PubMed ID: 12379092
    [No Abstract]   [Full Text] [Related]  

  • 5. Hair as a biological specimen for therapeutic drug monitoring.
    Beumer JH; Bosman IJ; Maes RA
    Int J Clin Pract; 2001; 55(6):353-7. PubMed ID: 11501221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring.
    Kruse W; Weber E
    Eur J Clin Pharmacol; 1990; 38(6):561-5. PubMed ID: 2373129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy.
    Bernard L; Vuagnat A; Peytavin G; Hallouin MC; Bouhour D; Nguyen TH; Vildé JL; Bricaire F; Raguin G; de Truchis P; Ghez D; Duong M; Perronne C
    Ann Intern Med; 2002 Oct; 137(8):656-9. PubMed ID: 12379065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring compliance to therapy during addiction treatments by means of hair analysis for drugs and drug metabolites using capillary zone electrophoresis coupled to time-of-flight mass spectrometry.
    Gottardo R; Fanigliulo A; Sorio D; Liotta E; Bortolotti F; Tagliaro F
    Forensic Sci Int; 2012 Mar; 216(1-3):101-7. PubMed ID: 21945303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline assay hair samples for testing long-term compliance treatment.
    Angelakis E; Armstrong N; Nappez C; Richez M; Chabriere E; Raoult D
    J Infect; 2015 Nov; 71(5):511-7. PubMed ID: 26299894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
    Straka RJ; Fish JT; Benson SR; Suh JT
    Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of R-(-)- and S-(+)-amphetamine in hair and blood by gas chromatography-mass spectrometry: an application to compliance monitoring in adult-attention deficit hyperactivity disorder treatment.
    Nyström I; Trygg T; Woxler P; Ahlner J; Kronstrand R
    J Anal Toxicol; 2005 Oct; 29(7):682-8. PubMed ID: 16419401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring compliance: a sensitive indicator of change.
    Huffman LM
    AANA J; 1992 Jun; 60(3):217-20. PubMed ID: 1632148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring?
    Kintz P; Marescaux C; Mangin P
    Hum Exp Toxicol; 1995 Oct; 14(10):812-5. PubMed ID: 8562122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient compliance in therapeutic trials.
    Lancet; 1991 Apr; 337(8745):823-4. PubMed ID: 1672918
    [No Abstract]   [Full Text] [Related]  

  • 15. Hair analysis for long-term monitoring of buprenorphine intake in opiate withdrawal.
    Pirro V; Fusari I; Di Corcia D; Gerace E; De Vivo E; Salomone A; Vincenti M
    Ther Drug Monit; 2014 Dec; 36(6):796-807. PubMed ID: 24713865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cocaine in abuser hairs by CE: monitoring compliance to a detoxification program.
    Baciu T; Borrull F; Calull M; Aguilar C
    Bioanalysis; 2015; 7(4):437-47. PubMed ID: 25747763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hair Analysis for the Retrospective and Prospective Consume-Monitoring: Substance Abuse, Abstinence- and Compliance Control].
    Binz TM; Baumgartner MR
    Praxis (Bern 1994); 2016 Jan; 105(1):17-21. PubMed ID: 26732713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient compliance to drug therapy.
    Rohatgi D; Lal A
    J Assoc Physicians India; 1998 May; 46(5):462-4, 467. PubMed ID: 11273292
    [No Abstract]   [Full Text] [Related]  

  • 19. Interindividual dose/concentration relationship for methadone in hair.
    Paterson S; Cordero R; McPhillips M; Carman S
    J Anal Toxicol; 2003; 27(1):20-3. PubMed ID: 12587678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.
    Mave V; Chandanwale A; Kinikar A; Khadse S; Kagal A; Gupte N; Suryavanshi N; Nimkar S; Koli H; Khwaja S; Bharadwaj R; Joshi S; Horng H; Benet LZ; Ramachandran G; Dooley KE; Gupta A; Gandhi M
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):844-7. PubMed ID: 27155191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.